Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Disruptive. Transformative. Empowering. Integrated Digital Care for the Future.

CareSpan Health Inc. ( TSX-V.CSPN , Forum ) is a disruptive, transformative, and empowering company providing a digital healthcare platform that integrates digital care tools, capabilities, and data in one place. The company's proprietary "Clinic-in-the Cloud" is a c...
Dave Jackson | January 24, 2022 |

Buzz on the Bullboards: Sell in May and go away?

As investors assess the strategy of liquidating positions before the summer, lingering concerns over an impending economic recession haven’t appeared to slow down activity on the Bullboards. Instead, as we approach zero hour on the deadline to settle t...
Jonathon Brown | May 25, 2023 |

Buzz on the Bullboards: Bulls on the Buzzboards

Do you believe in parallel dimensions, alternate realities? Somewhere where there is no COVID, European tensions are just that – tense, market volatility is kept to a minimum. It is here, perhaps, in the inversed Buzz, where everything is “fine”...
Stockhouse Editorial | March 9, 2022 |

Kardashian-Style News Bomb: Already Big Ashram Gets Bigger And Bigger

Bigger is Better (at least in this respect) What a pleasant surprise! The Ashram Rare Earth and Fluorspar Deposit continues to grow. As announced today by Commerce Resources Corp. , recent core assays for vertical drilling at Ashram has disc...
Stephan Bogner | November 28, 2019 |

PODCAST: Stockhouse Hosts Expert Panel on Battery Metals

Battery Metals have soared into prominence in recent years for mining investors. The term is derived from the primary metals (and mineral) inputs needed in the lithium-ion batteries that are powering electric vehicles and a host of other high-tech applications. This is part o...
Dave Jackson | May 14, 2019 |

Trader predicts Assets direction with this forward-looking indicator

Great traders are often the result of dedication to principle, theory, price study, and a solid understanding of Intermarket market dynamics. The one thing that can't be taught, though, is experience behind the screens and with the markets. The longer a trader spends work...
Chris Vermeulen | December 9, 2019 |

Tapping Into a Major Blue Sky Helium Opportunity

In a recent Stockhouse Media podcast , we introduced our investor audience to an intriguing mining play in the heart of Canada’s most prolific helium region – Southern Saskatchewan. No longer just the breadbasket of Canada, investors are now waking up to a ...
Dave Jackson | October 30, 2020 |

The Next Takeout Targets in Gold

There have been close to $6 billion in gold buyouts the last 2 weeks. Coming into tax loss season, it’s time to sharpen your pencils and get your cash ready for opportunities on the horizon. The deals that happened over the last 2 weeks should not co...
Marin Katusa | November 29, 2019 |

Acceleron Shares Open 50% Higher on Phase 2 PAH Trial Data

Acceleron Pharma's shares established a new 52-week high after the company reported that sotatercept achieved both primary and secondary endpoints in the Phase 2 PULSAR study in patients with pulmonary arterial hypertension. After U.S. markets closed for trading ye...
Streetwise Reports | January 29, 2020 |

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. ...
Streetwise Reports | April 28, 2020 |
1 2 3 4 5 6 7 8 9 10 ...